Furthermore, Castel et al. (2016) revealed that mTORC1 remained activated upon AKT suppression by a small-molecule inhibitor, BYL719, in breast cancer cells, owing to TSC2 phosphorylation by SGK1. Here, TSC2 is linked to breast carcinoma.